AMAG PharmaceuticalsのEBIT margin
AMAG PharmaceuticalsのEBIT marginは何ですか。
AMAG Pharmaceuticals, Inc.のEBIT marginは-66.23%です。
EBIT marginの定義は何ですか。
EBIT margin is a profitability ratio that measures earnings of the company as a percentage of revenue without taking into account the effect of taxes and interest.
ttm (trailing twelve months)
EBIT margin measures the profitability and operational efficiency of a company. It compares the amount of money that remains after the cost of goods and all operating expenses are subtracted from net revenue to sales. EBIT margin is calculated as earnings before interest and taxes divided by net revenue.
EBIT and EBIT margin evaluate how well a business manages its operations. Interest and taxes are not operating expenses and don’t impact operating efficiency. EBIT margin is usually used to compare operational efficiency and profitability of companies within the same industry. Taxes can vary by location thus excluding them from the calculation gives a better basis for comparing different companies.
EBIT and operating income are often used interchangeably, but there is a difference between them, which can cause the numbers to give different results. The key difference is that operating income does not include non-operating income, non-operating expenses, and other income.
NASDAQのセクタHealth CareにおけるEBIT marginの企業と比べるAMAG Pharmaceuticals
AMAG Pharmaceuticalsは何をしますか。
AMAG Pharmaceuticals, Inc. is a biopharmaceutical company. It focuses on the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. The firm focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. Its products include Intrarosa, Vyleesi, Makena, CBR, Feraheme, and MuGard. The company was founded on November 9, 1981 and is headquartered in Waltham, MA.
AMAG Pharmaceuticalsと類似のebit margin
- Senmiao Technology LtdのEBIT marginは-66.36%です。
- Take-Two Interactive SoftwareのEBIT marginは-66.33%です。
- Collagen Solutions plcのEBIT marginは-66.31%です。
- Guyana GoldfieldsのEBIT marginは-66.31%です。
- TilrayのEBIT marginは-66.31%です。
- GSI Technology IncのEBIT marginは-66.30%です。
- AMAG PharmaceuticalsのEBIT marginは-66.23%です。
- Amicus TherapeuticsのEBIT marginは-66.22%です。
- Forbidden FoodsのEBIT marginは-66.16%です。
- ASA Gold and Precious Metals LtdのEBIT marginは-66.12%です。
- SimiGonのEBIT marginは-66.07%です。
- Drone Volt SAのEBIT marginは-65.98%です。
- Vision CinemasのEBIT marginは-65.87%です。